{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:50:27Z","timestamp":1792799427012,"version":"4.5.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI137410-01"],"award-info":[{"award-number":["1R01AI137410-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24AI134990"],"award-info":[{"award-number":["K24AI134990"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>RTS,S\/AS01 is the first malaria vaccine to be approved and recommended for widespread implementation by the World Health Organization (WHO). Trials reported lower vaccine efficacies in higher-incidence sites, potentially due to a \u201crebound\u201d in malaria cases in vaccinated children. When naturally acquired protection in the control group rises and vaccine protection in the vaccinated wanes concurrently, malaria incidence can become greater in the vaccinated than in the control group, resulting in negative vaccine efficacies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using data from the 2009\u20132014 phase III trial (NCT00866619) in Lilongwe, Malawi; Kintampo, Ghana; and Lambar\u00e9n\u00e9, Gabon, we evaluate this hypothesis by estimating malaria incidence in each vaccine group over time and in varying transmission settings. After estimating transmission intensities using ecological variables, we fit models with 3-way interactions between vaccination, time, and transmission intensity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Over time, incidence decreased in the control group and increased in the vaccine group. Three-dose efficacy in the lowest-transmission-intensity group (0.25 cases per person-year [CPPY]) decreased from 88.2% to 15.0% over 4.5 years, compared with 81.6% to \u221227.7% in the highest-transmission-intensity group (3 CPPY).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These findings suggest that interventions, including the fourth RTS,S dose, that protect vaccinated individuals during the potential rebound period should be implemented for high-transmission settings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiac322","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T10:19:21Z","timestamp":1659003561000},"page":"1646-1656","source":"Crossref","is-referenced-by-count":14,"title":["Malaria Transmission Intensity Likely Modifies RTS, S\/AS01 Efficacy Due to a Rebound Effect in Ghana, Malawi, and Gabon"],"prefix":"10.1093","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4367-135X","authenticated-orcid":false,"given":"Griffin J","family":"Bell","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina , Chapel Hill, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Goel","sequence":"additional","affiliation":[{"name":"Carolina Population Center, University of North Carolina , Chapel Hill, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulin","family":"Essone","sequence":"additional","affiliation":[{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9 , Lambar\u00e9n\u00e9 , Gabon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dosoo","sequence":"additional","affiliation":[{"name":"Kintampo Health Research Centre , Kintampo , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3622-2137","authenticated-orcid":false,"given":"Bright","family":"Adu","sequence":"additional","affiliation":[{"name":"Noguchi Memorial Institute for Medical Research, University of Ghana , Legon , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicta Ayiedu","family":"Mensah","sequence":"additional","affiliation":[{"name":"Noguchi Memorial Institute for Medical Research, University of Ghana , Legon , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephaney","family":"Gyaase","sequence":"additional","affiliation":[{"name":"Kintampo Health Research Centre , Kintampo , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Wiru","sequence":"additional","affiliation":[{"name":"Kintampo Health Research Centre , Kintampo , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Mougeni","sequence":"additional","affiliation":[{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9 , Lambar\u00e9n\u00e9 , Gabon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musah","family":"Osei","sequence":"additional","affiliation":[{"name":"Kintampo Health Research Centre , Kintampo , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Minsoko","sequence":"additional","affiliation":[{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9 , Lambar\u00e9n\u00e9 , Gabon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Sinai","sequence":"additional","affiliation":[{"name":"Carolina Population Center, University of North Carolina , Chapel Hill, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karamoko","family":"Niar\u00e9","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Brown University , Providence, Rhode Island , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J","family":"Juliano","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, University of North Carolina , Chapel Hill, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hudgens","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina , Chapel Hill, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Ghansah","sequence":"additional","affiliation":[{"name":"Noguchi Memorial Institute for Medical Research, University of Ghana , Legon , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Portia","family":"Kamthunzi","sequence":"additional","affiliation":[{"name":"University of North Carolina Project , Lilongwe , Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tisungane","family":"Mvalo","sequence":"additional","affiliation":[{"name":"University of North Carolina Project , Lilongwe , Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selidji Todagbe","family":"Agnandji","sequence":"additional","affiliation":[{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9 , Lambar\u00e9n\u00e9 , Gabon"},{"name":"Institute of Tropical Medicine, University of T\u00fcbingen , T\u00fcbingen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A","family":"Bailey","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Brown University , Providence, Rhode Island , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwaku Poku","family":"Asante","sequence":"additional","affiliation":[{"name":"Kintampo Health Research Centre , Kintampo , Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Emch","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina , Chapel Hill, North Carolina , USA"},{"name":"Carolina Population Center, University of North Carolina , Chapel Hill, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"2023060109464683600_jiac322-B1","author":"World Health Organization"},{"key":"2023060109464683600_jiac322-B2","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0140-6736(08)60424-9","article-title":"A new global malaria eradication strategy","volume":"371","author":"Feachem","year":"2008","journal-title":"Lancet"},{"key":"2023060109464683600_jiac322-B3","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0140-6736(21)02235-2","article-title":"Malaria vaccine approval: a step change for global health","volume":"398","author":"The Lancet","year":"2021","journal-title":"Lancet"},{"key":"2023060109464683600_jiac322-B4","article-title":"Will RTS,S\/AS01 be the first malaria vaccine recommended as part of routine immunization to reduce illness and death in African children? [Symposium 76].","author":"Furrer"},{"key":"2023060109464683600_jiac322-B5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"RTS,S Clinical Trials Partnership","year":"2015","journal-title":"Lancet"},{"key":"2023060109464683600_jiac322-B6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-019-1277-x","article-title":"Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure","volume":"17","author":"Kurtovic","year":"2019","journal-title":"BMC Med"},{"key":"2023060109464683600_jiac322-B7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40471-021-00271-8","article-title":"Impacts of ecology, parasite antigenic variation, and human genetics on RTS,S\/AS01e malaria vaccine efficacy","volume":"8","author":"Bell","year":"2021","journal-title":"Curr Epidemiol Rep"},{"key":"2023060109464683600_jiac322-B8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1473-3099(19)30282-8","article-title":"Malaria vaccination and rebound malaria","volume":"19","author":"Dicko","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2023060109464683600_jiac322-B9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12936-022-04098-6","article-title":"Resurgent and delayed malaria","volume":"21","author":"Greenwood","year":"2022","journal-title":"Malar J"},{"key":"2023060109464683600_jiac322-B10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/infdis\/jir222","article-title":"Effect of the pre-erythrocytic candidate malaria vaccine RTS,S\/AS01E on blood stage immunity in young children","volume":"204","author":"Bejon","year":"2011","journal-title":"J Infect Dis"},{"key":"2023060109464683600_jiac322-B11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1074\/mcp.M114.044677","article-title":"RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites","volume":"14","author":"Campo","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"2023060109464683600_jiac322-B12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1473-3099(19)30300-7","article-title":"Long-term incidence of severe malaria following RTS,S\/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial","volume":"19","author":"Tinto","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2023060109464683600_jiac322-B13","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-year efficacy of RTS,S\/AS01 malaria vaccine among young African children","volume":"374","author":"Olotu","year":"2016","journal-title":"N Engl J Med"},{"key":"2023060109464683600_jiac322-B14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1207564","article-title":"Four-year efficacy of RTS,S\/AS01E and its interaction with malaria exposure","volume":"368","author":"Olotu","year":"2013","journal-title":"N Engl J Med"},{"key":"2023060109464683600_jiac322-B15","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1186\/s12889-020-09039-z","article-title":"Environmental modifiers of RTS,S\/AS01 malaria vaccine efficacy in Lilongwe, Malawi","volume":"20","author":"Bell","year":"2020","journal-title":"BMC Public Health"},{"key":"2023060109464683600_jiac322-B16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12889-021-10294-x","article-title":"Potential effect modification of RTS,S\/AS01 malaria vaccine efficacy by household socio-economic status","volume":"21","author":"Gyaase","year":"2021","journal-title":"BMC Public Health"},{"key":"2023060109464683600_jiac322-B17","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.1038\/s41598-017-07533-w","article-title":"RTS,S\/AS01 malaria vaccine efficacy is not modified by seasonal precipitation: results from a phase 3 randomized controlled trial in Malawi","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep"},{"key":"2023060109464683600_jiac322-B18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.pt.2021.03.003","article-title":"Satellite observations and malaria: new opportunities for research and applications","volume":"37","author":"Wimberly","year":"2021","journal-title":"Trends Parasitol"},{"key":"2023060109464683600_jiac322-B19","first-page":"261","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, April 2019\u2014conclusions and recommendations","volume":"94","author":"World Health Organization","year":"2019","journal-title":"Wkly Epidemiol Rec"},{"key":"2023060109464683600_jiac322-B20","doi-asserted-by":"crossref","DOI":"10.1057\/9780230509993","volume-title":"R News","author":"Liaw","year":"2002"},{"key":"2023060109464683600_jiac322-B21","author":"Malaria covariates."},{"key":"2023060109464683600_jiac322-B22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12942-021-00282-0","article-title":"Remote sensing of environmental risk factors for malaria in different geographic contexts","volume":"20","author":"McMahon","year":"2021","journal-title":"Int J Health Geogr"},{"key":"2023060109464683600_jiac322-B23","doi-asserted-by":"crossref","first-page":"22682","DOI":"10.3402\/gha.v7.22682","article-title":"Modelling heterogeneity in malaria transmission using large sparse spatio-temporal entomological data","volume":"7","author":"Rumisha","year":"2014","journal-title":"Glob Health Action"},{"key":"2023060109464683600_jiac322-B24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-072X-13-17","article-title":"Modeling larval malaria vector habitat locations using landscape features and cumulative precipitation measures","volume":"13","author":"McCann","year":"2014","journal-title":"Int J Health Geogr"},{"key":"2023060109464683600_jiac322-B25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4081\/gh.2016.434","article-title":"Random forest variable selection in spatial malaria transmission modelling in Mpumalanga Province, South Africa","volume":"11","author":"Kapwata","year":"2016","journal-title":"Geospat Health"},{"key":"2023060109464683600_jiac322-B26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12942-016-0051-y","article-title":"Mapping intra-urban malaria risk using high resolution satellite imagery: a case study of Dar es Salaam","volume":"15","author":"Kabaria","year":"2016","journal-title":"Int J Health Geogr"},{"key":"2023060109464683600_jiac322-B27","author":"Gelman"},{"key":"2023060109464683600_jiac322-B28","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2021"},{"key":"2023060109464683600_jiac322-B29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(13)70005-7","article-title":"Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data","volume":"13","author":"Bejon","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2023060109464683600_jiac322-B30","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1371\/journal.pmed.0040242","article-title":"Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation","volume":"4","author":"Aponte","year":"2007","journal-title":"PLoS Med"},{"key":"2023060109464683600_jiac322-B31","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(97)04229-3","article-title":"Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants","volume":"350","author":"Menendez","year":"1997","journal-title":"Lancet"},{"key":"2023060109464683600_jiac322-B32","doi-asserted-by":"crossref","first-page":"e23390","DOI":"10.1371\/journal.pone.0023390","article-title":"Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial","volume":"6","author":"Dicko","year":"2011","journal-title":"PLoS One"},{"key":"2023060109464683600_jiac322-B33","doi-asserted-by":"crossref","first-page":"e23391","DOI":"10.1371\/journal.pone.0023391","article-title":"Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial","volume":"6","author":"Konat\u00e9","year":"2011","journal-title":"PLoS One"},{"key":"2023060109464683600_jiac322-B34","first-page":"629","article-title":"Mortality and morbidity from malaria after stopping malaria chemoprophylaxis","volume-title":"Trans R Soc Trop Med Hyg","author":"Greenwood","year":"1995"},{"key":"2023060109464683600_jiac322-B35","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic diversity and protective efficacy of the RTS,S\/AS01 malaria vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N Engl J Med"},{"key":"2023060109464683600_jiac322-B36","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.vaccine.2018.01.069","article-title":"RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype","volume":"36","author":"Nielsen","year":"2018","journal-title":"Vaccine"},{"key":"2023060109464683600_jiac322-B37","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa2026330","article-title":"Seasonal malaria vaccination with or without seasonal malaria chemoprevention","volume":"385","author":"Chandramohan","year":"2021","journal-title":"N Engl J Med"},{"key":"2023060109464683600_jiac322-B38","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.vaccine.2020.04.031","article-title":"Case reduction and cost-effectiveness of the RTS,S\/AS01 malaria vaccine alongside bed nets in Lilongwe, Malawi","volume":"38","author":"Bell","year":"2020","journal-title":"Vaccine"},{"key":"2023060109464683600_jiac322-B39","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.medj.2021.10.003","article-title":"Delayed fractional dosing with RTS,S\/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies","volume":"2","author":"Das","year":"2021","journal-title":"Med"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiac322\/45262793\/jiac322.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/226\/9\/1646\/50499141\/jiac322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/226\/9\/1646\/50499141\/jiac322.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T09:47:37Z","timestamp":1685612857000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/226\/9\/1646\/6650987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,7,28]]},"published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiac322","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,7,28]]}}}